Binding of a CEA aptamer with the PELPK penta-peptide sequence can inhibit the binding ability of CEA with hnRNP M4 or DR5, which blocks liver metastasis and bestows anoikis sensitivity to cancer cells. This evidence concerns the gene CEACAM5 and cancer.